%0 Journal Article
%T Concurrent Capecitabine and Radiation Therapy for High-risk Primary Breast Cancer
%A Justin Famoso
%A Lauren G Lebeau
%A Michele B Ley
%A Pavani Chalasani
%A Rajayogesh Davuluri
%A Rebecca K Viscusi
%A Robert B Livingston
%A Tijana Skrepnik
%A Uma Goyal
%A Victor J Gonzalez
%J Oncomedicine
%D 2017
%R 10.7150/oncm.17910
%X Introduction: Data is limited for concurrent capecitabine-radiotherapy (CCRT) in primary breast cancer. We evaluated outcomes and toxicities of patients at high risk of locoregional recurrence receiving adjuvant CCRT.
%K breast cancer
%K capecitabine
%K high-risk
%K radiation
%U http://www.oncm.org/v02p0061.htm